Critical Risk Results - An Update on International Initiatives.
Direct communication of significant (often life-threatening) results is a universally acknowledged role of the pathology laboratory, and an important contributor to patient safety. Amongst the findings of a recent survey of 871 laboratories from 30 countries by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), only 3 tests were noted to be common to 90% of alert lists, and only 48% of laboratories consulted clinicians in developing these alert lists despite ISO15189 recommendations to do so. These findings are similar to previous national surveys demonstrating significant variation worldwide in how critical risk results are managed and also in how these protocols are developed. In order to promote "best practice" and harmonization of critical risk results management, guidelines and recommendations have been published, most recently by Clinical and Laboratory Standards Institute (CLSI) and Australasian Association of Clinical Biochemists (AACB). These statements in particular have placed strong emphasis on patient risk and risk assessment in the management of critical risk results. This focus has resulted in recommendations to adopt new terminology, the consideration of risk assessment when compiling alert tables, consultative involvement of laboratory users in setting up protocols, and the need for outcome-based evidence to support our practices. With time it is expected that emerging evidence and technological improvements will facilitate the advancement of laboratories down this path to harmonization, best practice, and improve patient safety.
Austin Pathology, Vic. , Australia.
Q
Q
Lam
Central Laboratory, Jósa Teaching Hospital of University of Debrecen Medical and Health Science Center , Nyíregyháza, Hungary.
E
E
Ajzner
Department of Clinical Chemistry and Endocrinology, South Eastern Area Laboratory Services, NSW Health Pathology, Australia; Australian Institute of Health Innovation, Macquarie University, NSW, Australia.
C A
CA
Campbell
Quest Diagnostics , PA, U.S.A.
A
A
Young
alert table; alert threshold; critical laboratory notification; critical laboratory results; critical risk results; harmonization
Clin Biochem Rev. 2012 Nov;33(4):141-8
23267246
Clin Chem. 2014 Dec;60(12):1569-70
25189694
J Med Assoc Thai. 2010 Nov;93 Suppl 6:S22-7
21280513
Clin Chem Lab Med. 2007;45(10):1411-3
17924852
Clin Biochem. 2009 Nov;42(16-17):1610-5
19683519
Ann Clin Biochem. 2003 Mar;40(Pt 2):181-4
12662409
Am J Clin Pathol. 2011 Jul;136(1):30-4
21685029
Clin Biochem. 2009 Nov;42(16-17):1658-61
19615355
Clin Chim Acta. 2014 May 15;432:135-47
24246790
Clin Biochem. 2009 Jun;42(9):766-70
19268438
Clin J Am Soc Nephrol. 2010 May;5(5):762-9
20203167
J Intensive Care. 2015 Aug 13;3(1):37
26269745
Biochem Med (Zagreb). 2015 Jun 05;25(2):193-202
26110031
Arch Pathol Lab Med. 2002 Jun;126(6):663-9
12033953
J Pathol Inform. 2011;2:53
22276244
Arch Pathol Lab Med. 2007 Dec;131(12):1769-75
18081434
Arch Pathol Lab Med. 2007 Jan;131(1):44-9
17227122
Clin Biochem Rev. 2015 Aug;36(3):97-105
26900189
Am J Clin Pathol. 2009 Mar;131(3):432-41
19228648
Clin Chem Lab Med. 2013 Sep;51(9):1803-13
23729574
Tidsskr Nor Laegeforen. 2013 Nov 12;133(21):E1-6
24226343
Arch Pathol Lab Med. 2008 Dec;132(12):1862-7
19061281
Clin Chem Lab Med. 2013 Nov;51(11):2099-107
23839815
Clin Biochem Rev. 2012 Nov;33(4):149-60
23267247
Clin Chem Lab Med. 2013 Apr;51(4):741-51
23435100
JAMA. 2012 Jan 11;307(2):157-64
22235086
Clin Med (Lond). 2015 Jun;15(3):239-43
26031972